TP53 disruption as a risk factor in the era of targeted therapies: A multicenter retrospective study of 525 chronic lymphocytic leukemia cases
Journal article published in 2021 by
Fortunato Morabito,
Giovanni Del Poeta,
Francesca Romana Mauro,
Gianluigi Reda 
,
Paolo Sportoletti,
Luca Laurenti ,
Marta Coscia,
Yair Herishanu ,
Sabrina Bossio,
Marzia Varettoni ,
Roberta Murru,
Annalisa Chiarenza,
Andrea Visentin ,
Adalgisa Condoluci,
Riccardo Moia
and other authors.
,
Paolo Sportoletti,
Luca Laurenti ,
Marta Coscia,
Yair Herishanu ,
Sabrina Bossio,
Marzia Varettoni ,
Roberta Murru,
Annalisa Chiarenza,
Andrea Visentin ,
Adalgisa Condoluci,
Riccardo Moia
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 